The quality of aged care provided to senior Australians will be significantly strengthened as Government measures come into effect today.
From 1 January 2020, the Aged Care Quality and Safety Commission will be bolstered with additional functions and responsibilities to safeguard the sector into the future, supported by a series of targeted investments aimed at improving compliance and quality.
In addition, new restrictions for prescriptions of the drug Risperidone today mark a tangible step toward reducing the level of chemical restraint used in aged care.
The changes support the Government’s initial response to the Royal Commission into Aged Care Quality and Safety’s Interim Report.
Minister for Aged Care Richard Colbeck said while important Government reforms – including the development of a new funding model – would continue, waiting for the final recommendations from the Royal Commission was vital to ensure long-term sustainable change.